Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) - Related Studies

Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

This study is ongoing, but not recruiting participants.

Study NCT00094861. Last updated on February 21, 2008. Information provided by Amgen

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Dysphagia
		Non-Small Cell Lung Cancer
		Lung Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Non-Small-Cell Lung
		Deglutition Disorders
		Lung Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Digestive System Diseases
		Esophageal Diseases
		Gastrointestinal Diseases
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Otorhinolaryngologic Diseases
		Pharyngeal Diseases
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		Palifermin
		Placebo

5	Sponsors listed in this trial
		Amgen